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CD8 Expression Allows T Cell Signaling
by Monomeric Peptide-MHC Complexes
The abTCR is an oligomeric complex containing both
ligand binding subunits (ab) and signal transducing sub-
units, i.e., the CD3 chains that possess immunoreceptor
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ITAMs, a step preferentially mediated by Lck. OnceCERVI
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ZAP-70, facilitating its subsequent phosphorylation and75013 Paris
activation (see Qian and Weiss, 1997, for a review). Thus,France
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hybridomas (Abastado et al., 1995; but see also WiestFrance
et al., 1996). Thus, homodimerization of the TCR-CD3
complex can trigger T cell activation.
Another possibility is that the initial event is the appo-Summary
sition of ITAM-bound ZAP-70 with Lck associated with
a coreceptor, CD4 or CD8. This hypothesis is supportedPhysiologically, TCR signaling is unlikely to result from
by the fact that a signaling cascade can be triggeredthe cross-linking of TCR-CD3 complexes, given the
by bispecific antibodies recognizing CD4 and CD3 (Ma-low density of specific peptide-MHC complexes on
drenas et al., 1997) and by the observation that a potentantigen-presenting cells. We therefore have tested di-
stimulation results from CD3-CD4 cross-linking (see,rectly an alternative model for antigen recognition. We
e.g., Anderson et al., 1987; Ledbetter et al., 1988). Thus,show that monomers of soluble peptide-MHC trigger
in addition to TCR-CD3 homodimerization, heterodimer-Ca21 responses in CD8ab1 T cells. This response is
ization of a coreceptor with the TCR would be an alterna-not observed in CD82 T cells and when either the
tive and nonexclusive way of triggering the T cell signal-CD8:MHC or CD8:Lck interactions are prevented. This
ing cascade.demonstrates that an intact CD8 coreceptor is neces-
In either case, the initial event could rapidly be ampli-sary for effective TCR signaling in response to mono-
fied by the formation of larger aggregates, as will bemeric peptide-MHC molecules. We propose that this
discussed later. However, there are flaws in both hy-heterodimerization of TCR and CD8 by peptide-MHC
potheses. With regard to the first one, one can objectcorresponds to the physiological event normally in-
that the density of pep-MHC complexes at the surfacevolved during antigen-specific signal transduction.
of antigen-presenting cells is unlikely to be high enough
to promote with a reasonable probability the engage-Introduction
ment of two contiguous TCRs and their subsequent di-
merization. Against the second hypothesis, it should beReceptor aggregation or conformational changes are
recalled that the requirement for coreceptor moleculestwo major ways by which signal transduction can be
is not always mandatory. In a large number of cases,initiated. The importance of receptor aggregation lead-
the presence of the CD4 or CD8 coreceptor has beening to the apposition of protein kinases has been well
shown to enhance antigen recognition. This facilitationestablished in the case of growth factor, cytokine, or Fc
has been attributed either to the slower dissociationreceptors (see Metzger, 1992, for a review). Concerning
rate of pep-MHC ligand from the TCR (Luescher et al.,antigen recognition by T cells, a large array of arguments
1995b; Garcia et al., 1996b), and/or to the recruitmentare in favor of signal transduction controlled by the ag-
of Lck to the TCR (Chalupny et al., 1991; Glaichenhausgregation of transmembrane proteins including the clo-
et al., 1991; Hoeveler and Malissen, 1993). However,notypic TCR (see, e.g., Germain, 1997; Qian and Weiss,
the recognition of some ligands shows little or even no1997). However, the exact nature of the molecules in-
sensitivity at all to the presence of the coreceptor, andvolved in the initial apposition event that catalyzes sig-
hybridomas lacking any coreceptor can respond to vari-naling and the precise role played by (later) protein clus-
ous pep-MHC complexes.tering remains unsettled.
This question is further complicated by the observa-
tion that one mechanism by which coreceptors facilitate‖ To whom correspondence should be addressed (e-mail: trautman@
T cell activation is by increasing adhesion between Twotan.ens.fr).




CD81 T Cells Expressing a TCR Transgene Respond
to Monomeric Peptide-MHC
As monomeric pep-MHC complexes have been widely
used in this study, it was important to first ascertain
their purity. Single-chain Kd was prepared from trans-
fected CHO cells, loaded with an antigenic peptide (Kd-
pep, see Experimental Procedures), and purified by two
consecutive gel filtrations using high performance FPLC.
Figure 1 shows that there is a single peak in the FPLC
profile, with no sign of shoulder at the position corre-
Figure 1. FPLC Profile of the Kd-HA Preparation sponding to dimers. These preparations were stored at
The arrows indicate the positions for monomers and dimers. The 48C and used to activate T cells within 24 hr. The purity
molecular weight markers were thyroglobulin (670 kDa), bovine
of the preparation remained unaltered 24 hr after thegamma globulin (158 kDa), chicken ovalbumin (44 kDa) and equine
FPLCs. In addition, incubation of monomeric Kd-pepmyoglobin (17 kDa).
complexes at 378C for more than 30 min failed to pro-
duce aggregates (data not shown).1989; Salter et al., 1990). Therefore, previous attempts
The ability of monomeric pep-MHC complexes to trig-to unravel the role of coreceptors may have been blurred
ger a functional response in T cells was first tested withby the superposition of different phenomena. In the
primed T cells obtained from CL4 TCR transgenic mice.present study, we circumvented this difficulty by stimu-
The CL4 mice (Morgan et al., 1996) express a TCRablating T cells with recombinant soluble peptide-MHC
transgene specific for influenza virus hemagglutinin (HA)complexes. This allowed us to demonstrate for the first
512-520 residues bound to Kd. As shown in Figure 2A,time that heterodimerization of a TCR and a CD8 mole-
Ca21 responses, monitored with an imaging system,cule with their physiological ligand, a monomeric MHC
were elicited in CL4 T cells at concentrations of Kd-pepmolecule loaded with the cognate peptide, triggers a
as low as 6 nM (0.3 mg/ml). Higher Kd-HA concentrationssignaling cascade leading to a full Ca21 response similar
elicited Ca21 responses of larger amplitude, in a largerto that triggered by divalent anti-CD3 antibodies. In ad-
proportion of cells and with a shorter delay (data notdition, we show that this heterodimerization does not
shown). High concentrations of Kd molecules loadedtrigger a Ca21 response when CD8 is mutated in a way
with an irrelevant peptide (ABA) gave no significant Ca21that prevents its association with Lck or when the
response (Figure 2A).CD8:MHC interaction is made impossible. The present
We next examined what happened when Kd-CD8 inter-findings clarify the previously puzzling evidence that
actions were prevented. The SF1-1.1.1 MAb recognizestarget cells having a single peptide-MHC complex per
an epitope on the a3 domain of Kd (Abastado et al.,cell, acting in effect like a monomeric ligand, can elicit
1993; Luescher et al., 1995b) that overlaps the bindingCD81 T cell cytolytic activity (Sykulev et al., 1996), and
site of CD8. Preincubation of monomeric Kd-pep withour recent observation that a few peptide-MHC com-
F(ab) fragments of SF1-1.1.1 reduced markedly the effi-plexes present in the contact zone between a dendritic
ciency with which Kd-HA elicited Ca21 responses in CL4cell and a naive CD41 T cell are sufficient to elicit a Ca21
response in the T cell (Delon et al., 1998b). T cells (Figures 2B and 2C). This result indicates that
Figure 2. Ca21 Responses in Transgenic T
Lymphocytes
(A) Ca21 responses elicited by different con-
centrations (0.3 to 10 mg/ml) of monomers of
Kd-HA in primed CD81 T cells purified from
CL4 transgenic mice. The trace show the av-
erages of all responding cells. The arrow indi-
cates the time when Kd-HA is added.
(B) Fab fragments of the anti-Kd MAb SF1-
1.1.1 prevent the CD8-Kd interaction and in-
hibit the Ca21 response elicited by 10 mg/ml
Kd-HA.
(C) Percentage of CL4 T cells presenting a
[Ca21]i increase in response to 10 mg/ml anti-
CD3 MAb, or to 10 mg/ml monomeric Kd-HA,
in the absence or presence of SF1-1.1.1. With
10 mg/ml, both anti-CD3 and Kd-HA stimula-
tions were submaximal, as judged by the per-
centage of responding cells. Data are from 3
independent experiments.
CD81 T Cell Activation by Monomeric Peptide-MHC
469
Figure 3. Phenotype of Hybridoma T Cells
FACS analysis of the expression of CD3 (KT3),
CD8a (H58-55-3) and CD8b (H35-17-2) in
T1.4, T1.4 CD8ab and T1.4 CD8a9b transfec-
tants.
CD8 is involved in the response of T cells to soluble greater than 3.5 mg/ml (70 nM), monomeric Kd-ABA com-
plexes triggered a consistent Ca21 response in T1.4pep-MHC.
CD8ab T cells, under conditions in which the purity of
the Kd-ABA preparation had been checked by FPLCCD8ab Transfectants of the T1.4 Hybridoma Respond
to Monomeric Peptide-MHC Complexes (data not shown), as demonstrated above for Kd-HA. To
rule out the possibility that T cell activation could resultTo analyze more precisely the role of CD8 in the re-
sponse to pep-MHC monomers, we switched to a more from an undetectable contamination by dimers of pep-
MHC, we purified spontaneous dimers by gel filtrationtractable system based on the CD82 T1.4 hybridoma
(GreÂ goire et al., 1996) and its corresponding CD8ab FPLC. Purified spontaneous dimers were used to acti-
vate T1.4 CD8ab cells. However, we found that theirtransfectant. The T1.4 TCR recognizes an H-2Kd re-
stricted Plasmodium berghei circumsporozoite peptide biological activity was always lower than that of the
same concentration of purified monomers (3 to 10 mg/ml,(SYIPSAEKI) that has been modified by conjugating the
TCR contact residue Lys-259 with 4-azidobenzoic acid in three experiments). Therefore, the activity of the
monomers is unlikely to be due to a minor contamination(ABA) (Luescher et al., 1995a). Cell surface expression
of the TCR/CD3 complex is comparable in both T1.4 by dimers.
While monomers of Kd-ABA (3.5 mg/ml) induced Ca21and its CD8ab derivative (T1.4 CD8ab). The CD8a and
CD8b subunits are only expressed in the T1.4 CD8ab responses in CD81 cells, they failed to do so in the CD82
parental T1.4 cells, even at 15 mg/ml (Figure 4B). Thisand CD8a9b transfectants (Figure 3).
As shown in Figure 4A, when used at concentration lack of response of T1.4 cells was not due to a general
Figure 4. Ca21 Responses in Hybridoma T
Cells
Ca21 responses elicited by monomers of Kd-
ABA in CD8ab1 T cells (A), in CD82 T cells
(B) and in CD8a9b1 T cells (D). The response
of the three transfectants to 10 mg/ml anti-




Figure 5. Ca21 Responses to Dimers of
Kd-ABA
Comparison of Ca21 responses evoked in
CD8ab1, CD8a9b1, and CD8a2b2 T cells. (A):
Responses to dimers of Kd-ABA (10 mg/ml).
(B): Percentage of responding T cells follow-
ing stimulation by anti-CD3, monomers or di-
mers of Kd-ABA. Data are from 3 independent
experiments.
defect in TCR-induced Ca21 signaling, because the Ca21 with the three transfectants (Figure 5B). The differences
responses elicited by anti-CD3 MAbs were similar in in the time course of the responses (Figure 5A) should
T1.4 (CD82) and in T1.4 CD8ab T cells (Figure 4C). not be overinterpreted, since there was a certain vari-
The T1.4 CD8ab transfectants as well as the trans- ability of the responses, also evident in the percentage
genic CL4 CD81 splenocytes used in this study all ex- of responding cells (Figure 5B). At least part of this
press Kd at their surface. It could therefore be argued variability could reflect the fact that the full dimerization
that at least part of the response was due to the dissocia- of Kd-ABA complexes in the presence of SF1-1.1.1 was
tion of the peptide from the exogenous Kd and its subse- difficult to ascertain. Besides, as the presence of the
quent loading on the Kd molecules expressed at the T dimerizing antibody SF1-1.1.1 prevents the CD8-MHC
cell surface. Such peptide exchange could not result in interaction, CD8 cannot contribute to the binding of di-
cell-cell presentation since, in our imaging experiments, mers of Kd-ABA. This may explain why CD81 cells do
the cell density was too low and most T cells were not not respond better to dimers of Kd-ABA than CD82 T
in contact with other cells. However, one cannot exclude cells.
a priori that membrane ruffles can fold back on the cell Collectively, our results indicate that T cells respond
resulting in self-presentation. This hypothesis is never- to dimers of pep-MHC whether CD8 is present or not.
theless quite unlikely for several reasons. (1) Such self- However, T cell responsiveness to monomeric pep-MHC
presentation should be observed upon addition of pep- requires much more stringent conditions. In this latter
tide alone, but peptide concentrations up to 0.2 mg/ml instance, the CD8 molecule must both bind extracellu-
(200 nM) failed to elicit any Ca21 response in T1.4 larly to MHC class I molecules and intracellularly to Lck.
CD8ab T cells. (2) When membrane ruffling was pre-
vented by treating the cells with cytochalasin D, Ca21
responses were still elicited by monomeric Kd-ABA (data Discussion
not shown).
This study provides the first direct experimental evi-
The Ca21 Response of a T Cell Hybridoma dence that the heterodimerization of TCR and CD8 mole-
to Monomeric Pep-MHC Complexes cules by monomers of MHC class I suffices to elicit Ca21
Requires an Intact CD8a responses in T cells. In fact, the T cell response observed
Cytoplasmic Tail with monomers was not limited to the early steps of
The mechanism by which CD8 allows T cells to respond signaling. A strong proliferative response was also ob-
to monomeric pep-MHC ligand could be through the served in highly purified CD81 T cells from CL4 mice
stabilization of the interaction between the TCR and its
stimulated for 24 hr by monomeric pep-Kd complexes
monomeric ligand and/or through the recruitment of Lck
(data not shown). Based on these results, we favor a
in the vicinity of the TCR-CD3 complex. To evaluate the
model in which activation of CD81 T cells can be initiatedimportance of Lck recruitment via CD8ab, we produced
either by homodimerization of the TCR or by heterodi-a T1.4 transfectant denoted T1.4 CD8a9b and in which
merization of TCR and CD8, the latter mode of activationthe extracellular portion of CD8a is unchanged but the
prevailing during the initial phases of antigen recognitionintracytoplamic tail is truncated and thus unable to asso-
on an APC.ciate with Lck. T1.4 CD8a9b T cells express levels of
In our experimental model, the active stimulus wasTCR/CD3 and CD8ab comparable to those of T1.4
monomeric pep-MHC. Therefore, there was no initialCD8ab cells (Figure 3) and fully respond to an anti-CD3
cross-linking of the ligand. However, it is quite possibleMAb (Figure 4C). As shown in Figure 4D, these cells,
that once initial trimers of pep-MHC, CD8, and TCR arehowever, failed to respond to monomeric Kd-ABA.
formed, TCR clustering then occurred (Germain, 1997;
Reich et al., 1997), thanks to low-affinity interactionsCD82 T Cells Respond to Dimeric
between the different partners of the elementary trimer,Pep-MHC Molecules
in particular between CD8 and the TCR (Arden, 1998;Finally, we evaluated to what extent T cells respond
Lim et al., 1998) or between the tyrosine kinases (Lckto dimers of pep-MHC. When Kd-ABA complexes were
and ZAP-70) associated with CD8 and the TCR-CD3dimerized with F(ab9)2 fragments of SF1-1.1.1 and sub-
complex (Viola et al., 1997). Similar interactions probablysequently added to T1.4 hybridomas, Ca21 responses
take place during the aggregation of MHC class II, CD4,were observed regardless of the presence of CD8 (Fig-
ure 5A). The percentage of responding cells was similar and TCR (see Sakihama et al., 1996, for a review). In
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this case, the existence of two distinct binding sites for Concerning the efficacy of TCR-CD8 heterodimeriza-
tion by monomers of pep-MHC, our results are appar-MHC class II on CD4 molecules (KoÈ nig et al., 1995), the
capacity of CD4 molecules to dimerize, as suggested ently at odds with those of Davis and colleagues, who
recently reported in a review that stimulation of the 2B4from structural data (Wu et al., 1997) or even to oligo-
merize as suggested by class II-CD4 binding data (Saki- T cell line with monomers or dimers of MCC/I-Ek failed
to evoke any acidification of the T cell media, whereashama et al., 1995), could further favor aggregation.
Moreover, homotypic interactions between MHC class trimers or tetramers were stimulatory (Davis et al., 1998).
Both kinds of experiments were performed on the sameII or TCR molecules may take place, as suggested from
structural data (Brown et al., 1993) and from the aggre- time scale, and we took all necessary precautions to
make sure that the responses were not due to the pres-gation observed when high-enough concentrations of
purified MHC class II and TCR are mixed in solution ence of MHC-pep aggregates (see above). We are not
aware of data allowing to estimate the involvement of(Reich et al., 1997). Finally, it has been proposed (Metz-
ger, 1992) and shown (Weis et al., 1982; Dustin et al., CD4:Lck in the response of 2B4 cells to oligomers of
pep-MHC. Besides, it is interesting to note that forma-1996) that even in the absence of lateral interactions,
a monomeric ligand can trigger receptor aggregation, tion of large size aggregates of FceRI is always stimula-
tory, whereas a simple dimerization can be stimulatorysimply by thermodynamic forces acting on a topologi-
cally constrained system (e.g., at the interface between or not, depending upon the amount of tyrosine kinase
(e.g., Lyn) available in the cells, a ratio that presumablytwo cell surfaces, with the possible involvement of mi-
crovilli). affects the fraction of receptors constitutively associ-
ated with the kinase (Vonakis et al., 1997). It is thusIs the TCR-CD8 heterodimerization always required?
The X-ray crystal structure of some pep-MHC com- conceivable that a similar variable, which could be the
fraction of TCR/CD3 complexes already associated withplexes bound to their cognate TCR has been recently
solved (Garboczi et al., 1996; Garcia et al., 1996a; Ding a Src family kinase before stimulation, controls the sen-
sitivity of the TCR to a simple dimerization.et al., 1998). The most striking finding is that all TCR
studied so far recognize their ligand with an almost iden- Is the presence of Lck necessary for the coreceptor
role of CD8? CD8 molecules can increase the apparenttical angle. This conserved topology may easily be ex-
plained if, as suggested in the present study, CD81 T affinity of pep-MHC for the TCR (Luescher et al., 1995b;
Kessler et al., 1997). Regardless of Lck recruitment, thiscell activation requires the apposition of the CD8:Lck
complex with the TCR-CD3:ZAP-70 complex via the si- increase in affinity should facilitate T cell stimulation
following TCR dimerization by antigen-presenting cellsmultaneous binding of pep-MHC to both TCR and CD8
(see also a discussion of these arguments in Germain presenting a high density of specific pep-MHC com-
plexes. However, when Lck is recruited by CD8, theet al., 1995). On the other hand, the puzzling existence
of clones that are coreceptor-independent strongly sug- coreceptor lowers the threshold of antigen detection
not only for quantitative reasons (increased affinity forgests that this mode of activation is not unique. Such
clones might have two characteristics: (1) CD8 cannot the binding of pep-MHC to the T cell) but, more impor-
tantly, for qualitative reasons, i.e., Lck recruitment lead-play its coreceptor role, possibly because an optimal
TCR-pep-MHC binding takes place with an orientation ing to a switch from a homodimerization to a heterodi-
merization mode of stimulation. Both CD8a, which bindsthat is not compatible with either CD8 binding to MHC
class I, or a close apposition of CD8:Lck with the ITAM- Lck, and CD8b, which does not but plays an indirect
role (Irie et al., 1998), contribute to this improvement inbound ZAP-70 molecules; (2) TCR-pep-MHC interaction
is sufficient to elicit a Ca21 response, under conditions antigen recognition (Wheeler et al., 1992; Renard et al.,
1996). Interestingly, the recruitment of the CD4 corecep-where a high-enough density of specific pep-MHC com-
plexes per se results in TCR homodimerization. The fact tor has been reported to lead to signaling events that
may be qualitatively distinct from those induced by CD3that some CD8-independent clones respond to peptide
concentrations comparable to those recognized by cross-linking (Madrenas et al., 1997).
In conclusion, we have shown that heterodimerizationCD8-dependent clones could reflect a high affinity of
the TCR for pep-MHC. It could also be due to an addi- of TCR and CD8 by monomeric pep-MHC leads to a
Ca21 response when CD8 can bind Lck, and it seemstional type of molecular interaction yet to be charac-
terized. very likely that this represents the principal mode of
How does TCR-CD8 heterodimerization compare to initiation of antigen-induced Ca21 responses in CD81 T
TCR homodimerization? We have previously shown, us- cells, even though at high antigen concentration homo-
ing a CD82 class I-restricted T hybridoma, that these dimerization of the TCR can constitute an alternate
cells secrete IL-2 in response to TCR dimerization (Abas- mode of initiation of the response.
tado et al., 1995). The poor efficacy of TCR homodimer-
ization in eliciting Ca21 responses that we observed with Experimental Procedures
dimers of pep-MHC is in line with previous observations,
Cellsfor instance the fact that in the T9.4 T cell line, Ca21
The CL4-TCR transgenic mice have been previously described (Mor-responses can be elicited by aggregation but not by
gan et al., 1996). These mice are transgenic for a Kd-restricted,simple dimerization of the TCR with anti-TCR antibodies
influenza virus hemagglutinin (HA) 512-520 peptide-specific TCR.(Ratcliffe et al., 1992). It also fits with the fact that hetero-
Four-month-old mice, backcrossed at least five times on the BALB/c
conjugates of CD3 and CD4 MAbs can be two orders of (H-2d) background, were used. CD81 splenocytes were purified and
magnitude more potent than anti-CD3 MAbs in inducing primed as previously described (Pardigon et al., 1998).
The CD82 T1.4 hybridoma (GreÂ goire et al., 1996) has been derivedCa21 responses in CD41 T cells (Ledbetter et al., 1988).
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